Pharma news

Reset all filters
Geography
Company
Refine search
Pfizer blames sales drop on patent expiries
Pharma
US pharmaceutical company Pfizer has reported that last year it saw a drop in sales revenue and has blamed it on the loss of certain important patents.   29 January 2015
Cipla appeals against Onbrez decision
Asia
Cipla has appealed against a decision by the Delhi High Court that blocked the generic drug maker from marketing copies of Novartis’s respiratory drug Onbrez (indacaterol) in India.   16 January 2015
Jazz plays on as Xyrem challenges quashed
Americas
The US Patent and Trademark Office has rejected several petitions that challenged a patent covering Jazz Pharmaceuticals’ narcolepsy drug Xyrem (sodium oxybate).   15 January 2015
Pharma
The Federal Court of Justice of Germany, the country’s highest court, has rejected an appeal from AstraZeneca in which the pharmaceutical company claimed that a patent used in its drug Seroquel XR (quetiapine) is valid.   14 January 2015
Asia
Glenmark Pharmaceuticals has been handed victory after the Indian Patent Office reversed a ruling that had granted a patent to US company Abbott Biotechnology for its anti-arthritis drug Humira (adalimumab).   9 January 2015
Americas
Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US.   8 January 2015
Pharma
Police in the UK have charged a man after accusing him of selling counterfeit drugs including erectile dysfunction and abortion medicines online.   7 January 2015
Americas
The US Food and Drug Administration has recommended that an application by pharmaceutical company Novartis to market a biosimilar version of Amgen’s cancer drug Neupogen (filgrastim) be approved.   5 January 2015
Americas
US pharmaceutical company Strategic Science and Technologies has signed an option agreement with “one of the world’s largest over-the-counter healthcare companies” to commercialise one of its ibuprofen products.   22 December 2014
Pharma
A decision by the CJEU on a Latvian case should make it easier in the future to challenge an MA granted for a generic version of a reference product, as Trevor Cook of WilmerHale explains.   19 December 2014